Bharat Seats Q1 FY27 Results (NSE: BHARATSE)
Signal: Steady quarter
The read
The key trajectory is strong top-line growth of 35.3% YoY to ₹57,782.61 lakh and PAT growth of 44.0% to ₹1,321.28 lakh, but the 163bps gross-margin compression to 12.9% is the principal watchpoint; lower finance costs of 12.4% YoY and slower growth in employee and other expenses supported profits, while the filing does not establish whether the margin pressure is transient or structural.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹577.83 Cr | +35.3% | +0.6% |
| EBIT | ₹0.2 Cr | N/A | |
| Net profit | ₹13.21 Cr | +44.0% | |
| EPS | ₹2.1 | +43.8% | |
| EBIT margin | 5.1% |
P&L walk
Standalone revenue was ₹57,782.61 lakh, +35.3% YoY and +0.6% QoQ, while EBITDA margin was 5.1%; PAT reached ₹1,321.28 lakh, +44.0% YoY, helped by lower finance costs and a lower effective tax burden despite gross-margin compression.
Key positives
- Revenue increased 35.3% YoY to ₹57,782.61 lakh, with the company also approving approximately Rs. 49.33 Crore of capex for new Maruti Suzuki programmes.
- PAT increased 44.0% YoY to ₹1,321.28 lakh, supported by finance-cost reduction of 12.4% YoY to ₹219.29 lakh.
- Employee benefits and other expenses increased 15.3% YoY versus revenue growth of 35.3%, indicating favourable opex intensity even though comparative EBITDA data is insufficient to confirm operating leverage.
- EPS increased 43.8% YoY to ₹2.10 and tracked PAT growth, with no evidence of dilution from the unchanged paid-up capital.
Key concerns
- Gross margin declined 163bps YoY to 12.9% despite revenue growth of 35.3%; the filing does not disclose whether the compression reflects pricing, product mix or input-cost factors.
- The company does not disclose volumes, realisations, capacity utilisation or order book, limiting assessment of whether growth is volume-led and how durable the new programme ramp-up will be.
Research and educational content only. Not investment advice.